Neural correlates of change in major depressive disorder anhedonia following open-label ketamine Read More > February 17, 2015
Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Read More > February 9, 2015
Ex vivo effects of ibogaine on the activity of antioxidative enzymes in human erythrocytes Read More > February 7, 2015
Ex vivo effects of ibogaine on the activity of antioxidative enzymes in human erythrocytes Read More > February 7, 2015
The Effect of Repeated Ketamine Infusion Over Facial Emotion Recognition in Treatment-Resistant Depression: A Preliminary Report Read More > February 6, 2015
Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers Read More > February 4, 2015
Forbidden therapies: Santo Daime, ayahuasca, and the prohibition of entheogens in Western society Read More > February 1, 2015
Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia Read More > February 1, 2015
